Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based Tinnitus

San Clemente, California, May 05, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nunzia Pharmaceutical Corporation (OTC MKTS: NUNZ), an emerging leader in innovative pharmaceutical and nutraceutical based therapies for the treatment of behavioral anxiety symptoms of Autistic Spectrum of Disorders (ASD’s) and other anxiety disorders, announces plans to start studies and effects on patients with anxiety-based tinnitus disorders.

Nunzia NUNZ and Dr. Roger Netzer, a medical doctor based in Hawaii, have agreed to start and evaluate on patients with Anxiety Based Tinnitus.

The patients will be selected by Dr. Netzer and we anticipate it to start this summer.

The timeline for the Evaluation is depending on availability due to the CoVid19 outbreak and closures of many institutions.

Dr. Netzer stated, "When the results are completed you will send the unbiased results to Nunzia."

Current treatments for ASD's have had limited efficacy, with broad acting drugs such as antidepressants, antipsychotics, SSRI's and amphetamines being employed to varying and inconsistent treatment results.  In addition to the unmet treatment needs for ASD's, NUNZIA also broadly treats a wide range of related anxiety disorders -- from ADHD which affects 4.8% of US adults and 8.7% of adolescents; to anxiety disorders (generalized, panic, and phobia related) that impact over a third of US adults and adolescents; and depressive disorders affecting up to 7.1% of the US adult population.

NUNZIA is currently available as a nutraceutical supplement, with prescribed and over-the-counter pharmaceutical treatments planned, and is unique within this space as a positive treatment quite unlike other drugs and supplements on the market. With no known negative side effects, no known addictions, and no clinical reaction to alcohol -- NUNZIA is one of the safest treatments on the market with no known adverse effects on vital organs. 

NUNZIA nutraceuticals are a combination of 16 vitamins, minerals, and herbs which directly focus and target the hippocampus area of the brain, where all anxiety-based disorders begin -- NUNZIA directly targets anxiety in the hippocampus, improving the function, which is a primary cause of the affiliations and compulsory disorders present in ASDs and anxiety disorders.  Treatment The NUNZIA supplement with NUNZIA has demonstrated positive results for affected patients, increased memory, improved fine motor skills and increased speech ability while decreasing the anxiety, stress, fixations, and fidgeting that complicate social interactions and life with ASDs and other anxiety disorders.